Follow The Filings

MRP Millrose Properties Inc.

Real Estate, filed as MILLROSE PPTYS INC (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 2 Owners
  • Max 4.0%
  • $188M
  • 1 add 1 reduce

In 2026 Q2 Bill Miller added to Millrose Properties, while Glenn Greenberg trimmed.

Who owns this now

Largest portfolio weights among holders, up to 4.0% (Glenn Greenberg, Brave Warrior Advisors). Not free-float ownership.

  1. Glenn Greenberg Reduce 4.0%
  2. Bill Miller Add 1.6%

Who owns MRP

Sorted by value, long equity only, as of 2026 Q2.

History
Glenn Greenberg, Brave Warrior Advisors 4.0%, was 5.9% Reduce −29.2% 6,030,725 $181M History
Bill Miller, Miller Value Partners 1.6%, was 1.3% Add +26.8% 229,300 $6.9M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MRP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MRP insider trades
  • $6.9M bought by 6 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Carlos A. Migoya Director
    Buy
    $29K 1,000 shares at $29.18 +3.4% to stake
    Traded Aug 7 Filed Aug 10
    ↗
  2. Matthew B. Gorson Director
    Buy
    $86K 3,000 shares at $28.80 +8.4% to stake
    Traded Aug 10 Filed Aug 10
    ↗
  3. Matthew B. Gorson Director
    Buy
    $121K 4,500 shares at $26.97 +14% to stake
    Traded May 18 Filed May 19
    ↗
  4. Rachel Presa General Counsel and Secretary
    Buy
    $28K 1,032 shares at $27.01 +70% to stake
    Traded May 11–13 Filed May 13
    ↗
  5. Robert Nitkin COO
    Buy
    $49K 1,840 shares at $26.60 +57% to stake
    Traded May 12 Filed May 13
    ↗
  6. Darren Richman See Remarks
    Buy
    $6.4M 235,000 shares at $27.31
    Traded May 11 Filed May 13
    ↗
  7. Matthew B. Gorson Director
    Buy
    $31K 1,000 shares at $30.67 +4.1% to stake
    Traded Mar 5 Filed Mar 9
    ↗
  8. Carlos A. Migoya Director
    Buy
    — 219 shares +1.3% to stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗
  9. Kathleen B. Lynch Director
    Buy
    $59K 1,860 shares at $31.74 +24% to stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗
  10. Carlos A. Migoya Director
    Buy
    $32K 1,000 shares at $32.24 +6.3% to stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
    ↗
  11. Rachel Presa General Counsel and Secretary
    Buy
    $15K 476 shares at $32.35 +48% to stake
    Traded Oct 30, 2025 Filed Oct 31, 2025
    ↗
  12. Matthew B. Gorson Director
    Buy
    $82K 2,500 shares at $32.69 +16% to stake
    Traded Oct 29, 2025 Filed Oct 30, 2025
    ↗
  13. Patrick J Bartels Jr. Director
    Buy
    $244K 7,500 shares at $32.52 +32% to stake
    Traded Oct 28, 2025 Filed Oct 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants and 1 other transaction.

Congress

1 member of Congress traded MRP in the last three years: 0 buys and 1 sale.

All Congress trades
  1. Jefferson Shreve R-IN-6 Sell $1K–$15K Feb 24, 2025 filed Mar 9, 2025
  2. Jefferson Shreve R-IN-6 Exchange $1K–$15K Feb 24, 2025 filed Mar 9, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.02,7.01,8.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2025
Revenue $600.46M
Net income $379.86M
Net margin * 63.3%

Balance sheet

Metric FY2025
Total assets $9.26B
Total equity $5.86B

Cash flow

Metric FY2025
Cash from operations $3.67B
Cash from investing -$5.72B
Cash from financing $2.08B
Net change in cash $35.05M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.